{
    "2019-04-27": [
        [
            {
                "time": "",
                "original_text": "【西南医药】泰格医药（300347）：业绩符合预期，主营业务延续高增长",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "业绩",
                        "主营业务",
                        "高增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药去年净利4.72亿同比增长57% 董事长叶小平薪酬71万",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利",
                        "同比增长",
                        "57%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}